Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offer...
Leadership
Mark L. Baum J.D.Founder
CEO, Chairman of the Board & Founder
Andrew R. Boll C.F.A., C.M.A.
President, CFO & Corporate Secretary
Amir W. Shojaei Ph.D., Pharm.D.
Chief Scientific Officer
Francis W. Mullery
President & CEO of Harrow's ImprimisRx Division
Randall E. Pollard
Chief Accounting Officer
Michael D. Biega
Vice President of Investor Relations & Communications
